Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

The effects of essential fatty acid supplementation by Efamol in hyperactive children.

Aman MG, Mitchell EA, Turbott SH.

J Abnorm Child Psychol. 1987 Mar;15(1):75-90.

PMID:
3553274
2.

EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors.

Stevens L, Zhang W, Peck L, Kuczek T, Grevstad N, Mahon A, Zentall SS, Arnold LE, Burgess JR.

Lipids. 2003 Oct;38(10):1007-21.

PMID:
14669965
3.

Patients with primary Sjögren's syndrome treated for two months with evening primrose oil.

Oxholm P, Manthorpe R, Prause JU, Horrobin D.

Scand J Rheumatol. 1986;15(2):103-8.

PMID:
3529370
4.

Evening primrose oil (Efamol) in the treatment of children with atopic eczema.

Bordoni A, Biagi PL, Masi M, Ricci G, Fanelli C, Patrizi A, Ceccolini E.

Drugs Exp Clin Res. 1988;14(4):291-7.

PMID:
3048953
5.

Atopic dermatitis and essential fatty acids: a biochemical basis for atopy?

Wright S.

Acta Derm Venereol Suppl (Stockh). 1985;114:143-5.

PMID:
3890448
6.
7.

Clinical characteristics and serum essential fatty acid levels in hyperactive children.

Mitchell EA, Aman MG, Turbott SH, Manku M.

Clin Pediatr (Phila). 1987 Aug;26(8):406-11.

PMID:
2439249
8.

A long-term study on the use of evening primrose oil (Efamol) in atopic children.

Biagi PL, Bordoni A, Masi M, Ricci G, Fanelli C, Patrizi A, Ceccolini E.

Drugs Exp Clin Res. 1988;14(4):285-90.

PMID:
3048952
10.

Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids).

Bamford JT, Gibson RW, Renier CM.

J Am Acad Dermatol. 1985 Dec;13(6):959-65.

PMID:
3908514
12.

A study of evening primrose seed oil in atopic asthma.

Ebden P, Bevan C, Banks J, Fennerty A, Walters EH.

Prostaglandins Leukot Essent Fatty Acids. 1989 Feb;35(2):69-72.

PMID:
2717651
13.

Essential fatty acids in the plasma phospholipids of patients with atopic eczema.

Manku MS, Horrobin DF, Morse NL, Wright S, Burton JL.

Br J Dermatol. 1984 Jun;110(6):643-8.

PMID:
6329254
14.
15.

Gamma-linolenic acid for attention-deficit hyperactivity disorder: placebo-controlled comparison to D-amphetamine.

Arnold LE, Kleykamp D, Votolato NA, Taylor WA, Kontras SB, Tobin K.

Biol Psychiatry. 1989 Jan 15;25(2):222-8.

PMID:
2539203
16.

Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response.

Morse PF, Horrobin DF, Manku MS, Stewart JC, Allen R, Littlewood S, Wright S, Burton J, Gould DJ, Holt PJ, et al.

Br J Dermatol. 1989 Jul;121(1):75-90.

PMID:
2667620
17.

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J.

Pediatrics. 1999 Apr;103(4):e43.

PMID:
10103335
20.

The influence of short-chain essential fatty acids on children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.

Raz R, Carasso RL, Yehuda S.

J Child Adolesc Psychopharmacol. 2009 Apr;19(2):167-77. doi: 10.1089/cap.2008.070.

PMID:
19364294
Items per page

Supplemental Content

Write to the Help Desk